Trials / Conditions / Reversible Cerebral Vasoconstriction Syndrome
Reversible Cerebral Vasoconstriction Syndrome
7 registered clinical trials studyying Reversible Cerebral Vasoconstriction Syndrome — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache NCT04580238 | University of Alberta | Phase 1 |
| Active Not Recruiting | Florida Cerebrovascular Disease Biorepository and Genomics Center NCT05491980 | Mayo Clinic | — |
| Completed | Endothelial Dysfunction in Reversible Cerebral Vasoconstriction Syndrome NCT04463212 | Nantes University Hospital | — |
| Recruiting | Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome NCT04179383 | University Hospital, Montpellier | N/A |
| Unknown | Reversible Cerebral Vasoconstriction Syndrome and Varicella Zoster Virus NCT03509701 | Asan Medical Center | — |
| Withdrawn | RCVS: The Rational Approach to Diagnosis and Treatment NCT03150524 | Johns Hopkins University | Phase 4 |
| Unknown | Perfusion MRI in Reversible Cerebral Vasoconstriction Syndrome NCT02756416 | University of Nottingham | N/A |